Tag: pharmaceutical firms

March 20, 2018

Antibe Therapeutics’ Share Price Soars with Positive Phase 2B Results

The company has released positive Phase 2B clinical trial results for its lead drug. The study was to evaluate the...
February 22, 2017

NeoGenomics Reports 122% Revenue Growth to $60.5 Million and 11% Reduction in Average Cost per Test in the Fourth Quarter of 2016

NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today reported its results for the fourth quarter...
July 27, 2016

SeeThru Equity Initiates Coverage of Q BioMed Inc. Price Target $3.85

Q BioMed Inc. (OTCQB:QBIO) is focused on identifying, acquiring and licensing attractive biomedical assets from small private companies and academia,...
June 23, 2016

Millendo Therapeutics Appoints New Independent Board Member and Names Chairperson of the Board

ANN ARBOR, Mich.–(BUSINESS WIRE)–Millendo Therapeutics, Inc., a company developing novel therapies for endocrine diseases caused by hormone dysregulation, today announced...
May 19, 2016

Evoke Enters Exclusive Commercial Supply Agreement for Active Pharmaceutical Ingredient in EVK-001

SOLANA BEACH, Calif., May 19, 2016 (GLOBE NEWSWIRE) — Evoke Pharma, Inc. (NASDAQ:EVOK), today announced that it has signed an...
April 25, 2016

Nutraceutical Industry Overview

A nutraceutical industry overview – a look at what is shaping the market.
February 2, 2016

DiaMedica Updates on DM199 Opportunity in South East Asia

DiaMedica Inc. (TSXV:DMA, OTCQB:DMCAF) provided investors with a corporate update.